Certuity’s Boston Scientific BSX Stock Holding History

Certuity’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$329K	Sell	5,250 -627	-11%	-$50.2K	0.02%	416
2025 Q4	$560K	Buy	5,877 +494	+9%	+$48.4K	0.04%	255
2025 Q3	$525K	Buy	5,383 +1,314	+32%	+$136K	0.04%	255
2025 Q2	$437K	Buy	4,069 +13	+0.3%	+$1.31K	0.04%	226
2025 Q1	$409K	Buy	4,056 +171	+4%	+$17.2K	0.04%	212
2024 Q4	$347K	Buy	3,885 +809	+26%	+$71.2K	0.04%	233
2024 Q3	$258K	Buy	3,076 +75	+2%	+$5.91K	0.03%	294
2024 Q2	$231K	Sell	3,001 -573	-16%	-$41.9K	0.02%	312
2024 Q1	$245K	Buy	3,574 +2	+0.1%	+$129	0.02%	275
2023 Q4	$207K	Buy	+3,572	New	+$191K	0.02%	317

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Certuity's BSX Position: Q1 2026 in Review

Certuity reduced its Boston Scientific (BSX) stake by 11% in Q1 2026, selling an estimated $50.2K and leaving 5,250 shares worth $329K. The position accounts for 0.02% of the portfolio, ranked #416.

Certuity first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $560K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Certuity held 5,250 shares of Boston Scientific worth $329K as of Q1 2026.
Certuity sold 627 Boston Scientific shares in Q1 2026, an estimated $50.2K.
Boston Scientific made up 0.02% of Certuity's portfolio in Q1 2026, its #416 holding.
Certuity first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Certuity's Boston Scientific position peaked at $560K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.